Behavioral Weight Loss Intervention Utilizing Mobile Health Technology in Hematopoietic Stem Cell Transplant Patients

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Pilot study enrolling obese post HSCT (hematopoietic stem cell transplantation) patients at the hematology/oncology clinic at the Mattel Children's Hospital, University of California, Los Angeles. Parameters include percent over the 95th percentile (%BMIp95), zBMI, fasting metabolic metrics, addictive eating habits, and motivation for change.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 13
Maximum Age: 30
Healthy Volunteers: t
View:

• Patients ≥ 13 and ≤ 30 years old with a history of HSCT of any type, at least 100 days post-transplant at initial consultation of the study, will be eligible for the study.

• Both male and female patients will be eligible.

• Patients must classify as obese, represented as Body mass index \[BMI\] ≥85th percentile for age and gender.

• Patients must also be able to read English since the app intervention is only available in English form.

Locations
United States
California
UCLA Mattel Children's Hospital
RECRUITING
Los Angeles
Contact Information
Primary
Andres Vargas
andresvargas@mednet.ucla.edu
3108256742
Time Frame
Start Date: 2021-08-15
Estimated Completion Date: 2026-01-09
Participants
Target number of participants: 20
Treatments
Experimental: App Group
Participants will be receiving an addiction model based mobile health (mHealth) weight loss intervention with coaching for a total of 4 months duration
Related Therapeutic Areas
Sponsors
Leads: University of California, Los Angeles

This content was sourced from clinicaltrials.gov